Latest Articles

Publication Date
Endometrial Cancer Treatment Market 2034: Clinical Trials, - openPR.com

Endometrial Cancer Treatment Market 2034: Clinical Trials, openPR.com

Published: April 4, 2025, 4:30 a.m.
Immune Dysregulation in Endometrial Tuberculosis: Elevated HLA-G and IL-1Ra as Key Modulators - Frontiers

Immune Dysregulation in Endometrial Tuberculosis: Elevated HLA-G and IL-1Ra as Key Modulators Frontiers

Published: April 4, 2025, 12:39 a.m.
Primary umbilical endometriosis in a nulliparous woman: A rare case report.

Endometriosis describes the presence of endometrial tissue outside the uterine cavity. These patients often experience cyclic pain, dysmenorrhea, dyspareunia and infertility. Extra-pelvic endometriosis, particularly at the umbilicus, is rare. The …

Published: April 4, 2025, midnight
SGO 2025: Impact of Precision Medicine in Endometrial Cancer - Medscape

SGO 2025: Impact of Precision Medicine in Endometrial Cancer Medscape

Published: April 3, 2025, 5:21 p.m.
Metformin Plus Letrozole & Abemaciclib Appears Safe, Effective in Endometrial Cancer - Oncology Nurse Advisor

Metformin Plus Letrozole & Abemaciclib Appears Safe, Effective in Endometrial Cancer Oncology Nurse Advisor

Published: April 3, 2025, 4 a.m.
'Ovariostasis' as the main preventive and therapeutic strategy for gynecological pathologies in women of reproductive age.

Ovariostasis is a reversible and temporary suspension of the cyclic ovarian activity, characterized by anovulation and hypogonadotropinemia (low serum concentrations of FSH and LH), which can be observed in case …

Published: April 3, 2025, midnight
Endometrial Nerve Fiber Density and Pain in Women With Endometriosis - Physician's Weekly

Endometrial Nerve Fiber Density and Pain in Women With Endometriosis Physician's Weekly

Published: April 2, 2025, 10:29 a.m.
Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position - TipRanks

Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position TipRanks

Published: April 1, 2025, 6:54 p.m.
Excess heme orchestrates progesterone resistance in uterine endometrial cancer through macrophage polarization and the IL-33/PAX8/PGR axis - ScienceDirect.com

Excess heme orchestrates progesterone resistance in uterine endometrial cancer through macrophage polarization and the IL-33/PAX8/PGR axis ScienceDirect.com

Published: April 1, 2025, 2:47 p.m.
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR - Nature

Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR Nature

Published: April 1, 2025, 1:15 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!